5 completed. 5 Phase 3, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 5 | Completed 5 |
| Phase 2 | 1 | Completed 1 |
Follow Glomerulosclerosis, Focal Segmental: new trials by email Literature Review of Glomerulosclerosis, Focal Segmental trials Research Report on Glomerulosclerosis, Focal Segmental
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Study of Sparsentan in Patients With Primary Focal Segmental Glomerulosclerosis (FSGS) sparsentan, Irbesartan - Focal Segmental Glomerulosclerosis | Phase 3 | Completed | Travere Therapeutics, Inc. | 371 | 2018-04-17 | 2026-04-17 |
| Efficacy of Rituximab For the Treatment of Calcineurin Inhibitors Dependent Nephrotic Syndrome During Childhood Rituximab, Placebo - Childhood Idiopathic Nephrotic Syndrome | Phase 2 / Phase 3 | Completed | University Hospital, Limoges | 26 | 2010-12-01 | 2015-03-23 |
| Focal Segmental Glomerulosclerosis Clinical Trial (FSGS-CT) Cyclosporin, Mycophenolate mofetil and Dexamethasone - Glomerulosclerosis, Focal | Phase 3 | Completed | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | 192 | 2004-11-01 | 2026-09-18 |
| Steroid Treatment for Kidney Disease Oral dexamethasone - Nephrosis, Focal Lipoid Glomerulosclerosis | Phase 3 | Completed | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | 8 | 2003-07-01 | 2011-10-28 |
| Mycophenolate Mofetil in Membranous Nephropathy and Focal Segmental prednisolone and mycophenolate mofetil, prednisolone and chlorambucil - Glomerulonephritis, Membranous, Glomerulosclerosis, Focal | Phase 3 | Completed | Hospital Authority, Hong Kong | 16 | 2003-01-01 | 2013-10-23 |
Nephrosis, Lipoid (2) · Glomerulonephritis, Membranous (1) · Kidney Diseases (1) · Macular dystrophy, corneal type 1 (1) · Nephrosis (1) · Nephrotic Syndrome (1) · Osteoporosis (1) · Proteinuria (1)
Female Urogenital Diseases (5) · Female Urogenital Diseases and Pregnancy Complications (5) · Glomerulonephritis (5) · Male Urogenital Diseases (5) · Nephritis (5) · Urogenital Diseases (5) · Urologic Diseases (5) · Kidney Diseases (4) · Autoimmune Diseases (1) · Bone Diseases (1) · Bone Diseases, Metabolic (1) · Immune System Diseases (1) · Metabolic Diseases (1) · Musculoskeletal Diseases (1) · Nephrosis (1)
Dexamethasone (2) · Mycophenolic Acid (2) · Chlorambucil (1) · Cyclosporine (1) · Irbesartan (1) · Prednisolone (1) · Rituximab (1) · sparsentan (1)
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) (2) · Hospital Authority, Hong Kong (1) · Travere Therapeutics, Inc. (1) · University Hospital, Limoges (1)
United States (3) · Belgium (2) · France (2) · Argentina (1) · Australia (1) · Brazil (1) · Canada (1) · China (1) · Croatia (1) · Czechia (1) · Denmark (1) · Estonia (1) · Germany (1) · Hong Kong (1) · Italy (1)
Aaron Friedman, MD (1) · Daniel TM Chan, Prof (1) · Marva Moxey-Mims, MD, FAAP (1) · Radko Komers, MD, PhD (1)
PMID 35224732, PMID 40337980, PMID 21178977, PMID 21734640, PMID 33412162, PMID 34778952, PMID 37254256, PMID 37921461, PMID 39513526, PMID 40938675, PMID 41433094
U01DK063385 (1), U01DK063455 (1), U01DK063490 (1), U01DK063549 (1)